Publication | Closed Access

Pathologic Nonresponders after Neoadjuvant Chemoradiation for Esophageal Cancer Demonstrate no Survival Benefit Compared with Patients Treated with Primary Esophagectomy

EsophagusEsophageal CancerGastrointestinal OncologyMedicineEsophageal Cancer DemonstrateThoracic SurgerySurgeryPathologic NonrespondersOncologyRadiation OncologyPrimary EsophagectomyEsophageal SurgeryCancer ResearchRadiologyHealth Sciences